Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up
Top Cited Papers
- 27 July 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 122 (4), 325-332
- https://doi.org/10.1161/circulationaha.110.937409
Abstract
Background— Monitoring implantable cardiac device function and patient condition is important. The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial tested the hypothesis that remote home monitoring with automatic daily surveillance (HM) is safe and effective for implantable cardioverter-defibrillator follow-up for 1 year and enables rapid physician evaluation of significant events. Methods and Results— In total, 1339 patients were randomized 2:1 to HM or conventional follow-up. Follow-up checks occurred at 3, 6, 9, 12, and 15 months after implantation. HM was used before office visits at 3 and 15 months in the HM group. At 6, 9, and 12 months, HM only was used but was followed by office visits if necessary. Conventional patients were evaluated with office visits only. Scheduled office visits and unscheduled evaluations, incidence of morbidity, and time elapsed from first event occurrence in each patient to physician evaluation were tracked for each group. HM and conventional patients were similar (age, 63.3±12.8 versus 64.0±12.1 years; gender, 72.0% versus 73.1% male; New York Heart Association class II, 55.9% versus 60.4%; pathology: left ventricular ejection fraction, 29.0±10.7% versus 28.5±9.8%; coronary artery disease, 64.8% versus 71.7%; primary prevention indication, 72.2% versus 73.8%; and dual-chamber implants, 57.8% versus 56.6%). HM reduced total in-hospital device evaluations by 45% without affecting morbidity. In the HM group, 85.8% of all 6-, 9-, and 12-month follow-ups were performed remotely only, indicating that HM provided sufficient assessment in the majority. Median time to evaluation was P Conclusions— HM is safe and allows more rapid detection of actionable events compared with conventional monitoring in patients with implantable electronic cardiac devices. Clinical Trials Registration—URL: http:/www.clinicaltrials.gov. Unique identifier: NCT00336284.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Benefits of Remote Versus Transtelephonic Monitoring of Implanted PacemakersJournal of the American College of Cardiology, 2009
- Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: Developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)Heart Rhythm, 2009
- Remote Monitoring for Advisories: Automatic Early Detection of Silent Lead FailurePacing and Clinical Electrophysiology, 2009
- Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter‐Defibrillators Assessed by Remote MonitoringPacing and Clinical Electrophysiology, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic SurgeonsJournal of the American College of Cardiology, 2008
- Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial FibrillationJournal of the American College of Cardiology, 2008
- Remote, Wireless, Ambulatory Monitoring of Implantable Pacemakers, Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Systems: Analysis of a Worldwide DatabasePacing and Clinical Electrophysiology, 2007
- Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines: Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE)Heart Rhythm, 2006
- Detection of Atrial Fibrillation by Implanted Devices with Wireless Data Transmission CapabilityPacing and Clinical Electrophysiology, 2005
- Remote Monitoring of Implantable Cardioverter Defibrillators:Pacing and Clinical Electrophysiology, 2004